Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

37.25
Delayed Data
As of 4:00pm ET
 -1.10 / -2.87%
Today’s Change
24.65
Today|||52-Week Range
50.05
-6.52%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Schwabe Stefan K F
Executive Vice President-Research & Development
Sale9/07/201795,000$46.58$4.4M-19.77%
Vaughn Victor L
Senior Vice President-Sales
Sale1/02/201855,000$40.11$2.2M-5.19%
Patrick Gregory S
Chief Financial Officer & Vice President
Sale1/11/201850,000$43.56$2.2M-14.30%
Patrick Gregory S
Chief Financial Officer & Vice President
Sale4/24/201754,000$32.37$1.7M+18.36%
Schwabe Stefan K F
Executive Vice President-Research & Development
Buy9/07/201795,000$12.92$1.2M-19.77%
Patrick Gregory S
Chief Financial Officer & Vice President
Sale9/07/201725,000$46.36$1.2M-19.77%
Patrick Gregory S
Chief Financial Officer & Vice President
Sale9/08/201723,481$48.89$1.1M-21.09%
Bhatt Padmanabh P
Sale1/22/201820,000$48.04$960.8K-13.33%
Bhatt Padmanabh P
Sale1/17/201820,000$44.98$899.6K-17.53%
Vaughn Victor L
Senior Vice President-Sales
Sale1/17/201815,000$47.03$705.5K-17.53%
Page of 5